These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9444976)

  • 1. Modulation of class I major histocompatibility complex antigen cell-surface stability by transmembrane domain length variation.
    Osborn CK; Grigoriev V; Crew MD
    Mol Immunol; 1997 Aug; 34(11):771-80. PubMed ID: 9444976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2.
    Thilo C; Berglund P; Applequist SE; Yewdell JW; Ljunggren HG; Achour A
    J Biol Chem; 2006 Mar; 281(13):8950-7. PubMed ID: 16452487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.
    Alexander J; Payne JA; Shigekawa B; Frelinger JA; Cresswell P
    Immunogenetics; 1990; 31(3):169-78. PubMed ID: 2318516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
    Wei ML; Cresswell P
    Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression level variation between two common Human Leukocyte Antigen alleles, HLA-A2 and HLA-B8, is dependent on the structure of the C terminal part of the alpha 2 and the alpha 3 domains.
    Dellgren C; Nehlin JO; Barington T
    PLoS One; 2015; 10(8):e0135385. PubMed ID: 26258424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of major histocompatibility complex class 1 (MHC-I) from squirrel monkeys (Saimiri sciureus).
    Pascalis H; Heraud JM; Fendel R; Lavergne A; Kazanji M
    Immunogenetics; 2003 Dec; 55(9):633-9. PubMed ID: 14574519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor escape from immune recognition: loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6.
    Maeurer MJ; Gollin SM; Storkus WJ; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze MT
    Clin Cancer Res; 1996 Apr; 2(4):641-52. PubMed ID: 9816214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
    Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
    Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficiency of folding and peptide loading of mutant MHC class I molecules.
    Beissbarth T; Sun J; Kavathas PB; Ortmann B
    Eur J Immunol; 2000 Apr; 30(4):1203-13. PubMed ID: 10760810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
    Storkus WJ; Salter RD; Alexander J; Ward FE; Ruiz RE; Cresswell P; Dawson JR
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):5989-92. PubMed ID: 2068075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29.
    Wang Z; Seliger B; Mike N; Momburg F; Knuth A; Ferrone S
    Cancer Res; 1998 May; 58(10):2149-57. PubMed ID: 9605759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins.
    Carey BW; Kim DY; Kovacs DM
    Biochem J; 2007 Jan; 401(1):121-7. PubMed ID: 17150042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain structure, intracellular trafficking, and beta2-microglobulin binding of a major histocompatibility complex class I homolog encoded by molluscum contagiosum virus.
    Senkevich TG; Moss B
    Virology; 1998 Oct; 250(2):397-407. PubMed ID: 9792850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
    Gao GF; Tormo J; Gerth UC; Wyer JR; McMichael AJ; Stuart DI; Bell JI; Jones EY; Jakobsen BK
    Nature; 1997 Jun; 387(6633):630-4. PubMed ID: 9177355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association with beta 2-microglobulin controls the expression of transfected human class I genes.
    Rein RS; Seemann GH; Neefjes JJ; Hochstenbach FM; Stam NJ; Ploegh HL
    J Immunol; 1987 Feb; 138(4):1178-83. PubMed ID: 3543123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of natural killer cells with MHC class II: reversal of HLA-DR1-mediated protection of K562 transfectant from natural killer cell-mediated cytolysis by brefeldin-A.
    Jiang YZ; Couriel D; Mavroudis DA; Lewalle P; Malkovska V; Hensel NF; Dermime S; Molldrem J; Barrett AJ
    Immunology; 1996 Mar; 87(3):481-6. PubMed ID: 8778037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.